Samrat Pharmachem [SAMRATPH] vs Styrenix Performance [STYRENIX] Detailed Stock Comparison

Samrat Pharmachem Ltd.

BSE
Loading...

Styrenix Performance Materials Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Samrat Pharmachem Ltd. wins in 7 metrics, Styrenix Performance Materials Ltd. wins in 12 metrics, with 0 ties. Styrenix Performance Materials Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Samrat Pharmachem Ltd. Styrenix Performance Materials Ltd. Better
P/E Ratio (TTM) 39.68 24.75 Styrenix Performance Materials Ltd.
Price-to-Book Ratio 0.98 3.29 Samrat Pharmachem Ltd.
Debt-to-Equity Ratio 15.49 44.08 Samrat Pharmachem Ltd.
PEG Ratio -0.34 -0.38 Samrat Pharmachem Ltd.
EV/EBITDA -93.75 18.19 Styrenix Performance Materials Ltd.
Profit Margin (TTM) -0.58% 4.66% Styrenix Performance Materials Ltd.
Operating Margin (TTM) -1.33% 1.44% Styrenix Performance Materials Ltd.
EBITDA Margin (TTM) N/A 1.44% N/A
Return on Equity 9.91% 20.14% Styrenix Performance Materials Ltd.
Return on Assets (TTM) 5.85% 10.26% Styrenix Performance Materials Ltd.
Free Cash Flow (TTM) $-105.99M $-3.82B Samrat Pharmachem Ltd.
Dividend Yield 0.29% 2.80% Styrenix Performance Materials Ltd.
1-Year Return -37.34% -27.51% Styrenix Performance Materials Ltd.
Price-to-Sales Ratio (TTM) 0.24 1.16 Samrat Pharmachem Ltd.
Enterprise Value $597.84M $46.17B Styrenix Performance Materials Ltd.
EV/Revenue Ratio 0.21 1.30 Samrat Pharmachem Ltd.
Gross Profit Margin (TTM) 2.59% 22.15% Styrenix Performance Materials Ltd.
Revenue per Share (TTM) $936 $2,019 Styrenix Performance Materials Ltd.
Earnings per Share (Diluted) $-5.42 $94.19 Styrenix Performance Materials Ltd.
Beta (Stock Volatility) -0.35 0.34 Samrat Pharmachem Ltd.

Samrat Pharmachem Ltd. vs Styrenix Performance Materials Ltd. Stock Performance Analysis

Loading Price Chart...

SAMRATPH
STYRENIX

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Samrat Pharmachem Ltd.-0.22%-8.21%-2.79%2.34%-20.83%-8.96%
Styrenix Performance Materials Ltd.-1.39%-1.65%-0.61%19.11%8.02%10.05%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Samrat Pharmachem Ltd.-37.34%-40.14%-1.85%833.96%1,047.00%2,384.03%
Styrenix Performance Materials Ltd.-27.51%160.17%55.99%279.89%326.65%1,649.71%

Performance & Financial Health Analysis: Samrat Pharmachem Ltd. vs Styrenix Performance Materials Ltd.

MetricSAMRATPHSTYRENIX
Market Information
Market Cap i₹676.34M₹41.02B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i1,76051,222
90 Day Avg. Volume i2,39151,528
Last Close₹207.35₹2,231.70
52 Week Range₹190.00 - ₹389.00₹1,780.00 - ₹3,498.00
% from 52W High-46.70%-36.20%
All-Time High₹1,250.00 (Sep 19, 2022)₹3,498.00 (Jun 09, 2025)
% from All-Time High-83.41%-36.20%
Growth Metrics
Quarterly Revenue Growth0.00%0.26%
Quarterly Earnings Growth0.00%-0.66%
Financial Health
Profit Margin (TTM) i-0.01%0.05%
Operating Margin (TTM) i-0.01%0.01%
Return on Equity (TTM) i0.10%0.20%
Debt to Equity (MRQ) i15.4944.08
Cash & Liquidity
Book Value per Share (MRQ)₹228.64₹708.41
Cash per Share (MRQ)₹62.79₹18.64
Operating Cash Flow (TTM) i₹1.26M₹-3,519,400,000
Levered Free Cash Flow (TTM) i₹71.12M₹2.35B
Dividends
Last 12-Month Dividend Yield i0.29%2.80%
Last 12-Month Dividend i₹1.00₹54.00

Valuation & Enterprise Metrics Analysis: Samrat Pharmachem Ltd. vs Styrenix Performance Materials Ltd.

MetricSAMRATPH (Apr 24, 2026)STYRENIX (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i39.6824.75
Forward P/E iN/A19.79
PEG Ratio i-0.34-0.38
Price to Sales (TTM) i0.241.16
Price to Book (MRQ) i0.983.29
Market Capitalization
Market Capitalization i₹676.34M₹41.02B
Enterprise Value i₹597.84M₹46.17B
Enterprise Value Metrics
Enterprise to Revenue i0.211.30
Enterprise to EBITDA i-93.7518.19
Risk & Other Metrics
Beta i-0.350.34
Book Value per Share (MRQ) i₹228.64₹708.41

Financial Statements Comparison: Samrat Pharmachem Ltd. vs Styrenix Performance Materials Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricSAMRATPH (2025)STYRENIX (2025)
Revenue/Sales i2.86B29.82B
Cost of Goods Sold i2.71B22.33B
COGS % of Revenue i94.7%74.9%
Gross Profit i152.75M7.50B
Gross Margin i5.3%25.1%
Research & Development i0N/A
Operating Income (EBIT) i97.54M3.02B
Operating Margin i3.4%10.1%
EBITDA i107.17M3.55B
EBITDA Margin i3.7%11.9%
Pre-Tax Income i98.86M3.04B
Pre-Tax Income % of Revenue i3.5%10.2%
Income Tax i27.74M686.30M
Income Tax % of Revenue i1.0%2.3%
Net Income (Profit) i71.12M2.35B
Profit Margin i2.5%7.9%

Balance Sheet & Liquidity Metrics

MetricSAMRATPH (2025)STYRENIX (2025)
Cash & Equivalents i483,000976.50M
Total Current Assets i1.03B13.61B
Total Current Assets % of Revenue i36.2%45.6%
Total Current Liabilities i495.83M6.61B
Total Current Liabilities % of Revenue i17.3%22.1%
Long-Term Debt i03.77B
Long-Term Debt % of Revenue i0.0%12.6%
Total Shareholders Equity i718.00M11.68B
Retained Earnings i687.11M7.40B
Retained Earnings % of Revenue i24.0%24.8%
Property, Plant & Equipment i08.53B

Cash Flow Statement Comparison

MetricSAMRATPH (2025)STYRENIX (2025)
Operating Cash Flow i1.26M-3.52B
Operating Cash Flow % of Revenue i0.0%-11.8%
Capital Expenditures i-5.07M-4.36B
Free Cash Flow i-105.99M-3.82B
FCF Margin i-3.7%-12.8%
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSAMRATPHSTYRENIX
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i3.09M17.59M
Float Shares i1.19M8.96M
% Held by Insiders i59.26%48.50%
% Held by Institutions i0.00%15.59%
% Held by Public i40.74%35.91%

Dividend Analysis & Yield Comparison: Samrat Pharmachem Ltd. vs Styrenix Performance Materials Ltd.

MetricSAMRATPHSTYRENIX
Last 12-Month Dividend i₹1.00₹54.00
Last 12-Month Dividend Yield i0.29%2.80%
3-Year Avg Annual Dividend i₹1.67₹95.67
3-Year Avg Dividend Yield i0.17%2.83%
3-Year Total Dividends i₹5.00₹287.00
Ex-Dividend DateSep 19, 2024Feb 05, 2026